File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways

TitleEpigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways
Authors
Xiao, JHo, MCTLiong, ECNanji, AALeung, TMLau, TYHFung, MLTipoe, GL
KeywordsEGCG
Fibrosis
Inflammation
NAFLD
Oxidative stress
Issue Date2014
PublisherSpringer Medizin. The Journal's web site is located at http://www.springer.com/steinkopff/journal/394
Citation
European Journal of Nutrition, 2014, v. 53 n. 1, p. 187-199 How to Cite?
DOI: http://dx.doi.org/10.1007/s00394-013-0516-8
Persistent Identifierhttp://hdl.handle.net/10722/195657
ISSN
1436-6207
2023 Impact Factor: 4.1
2023 SCImago Journal Rankings: 1.167
ISI Accession Number ID
WOS:000331079500017

 

DC FieldValueLanguage
dc.contributor.authorXiao, Jen_US
dc.contributor.authorHo, MCTen_US
dc.contributor.authorLiong, ECen_US
dc.contributor.authorNanji, AAen_US
dc.contributor.authorLeung, TMen_US
dc.contributor.authorLau, TYHen_US
dc.contributor.authorFung, MLen_US
dc.contributor.authorTipoe, GLen_US
dc.date.accessioned2014-03-07T04:20:57Z-
dc.date.available2014-03-07T04:20:57Z-
dc.date.issued2014en_US
dc.identifier.citationEuropean Journal of Nutrition, 2014, v. 53 n. 1, p. 187-199en_US
dc.identifier.issn1436-6207-
dc.identifier.urihttp://hdl.handle.net/10722/195657-
dc.languageengen_US
dc.publisherSpringer Medizin. The Journal's web site is located at http://www.springer.com/steinkopff/journal/394-
dc.relation.ispartofEuropean Journal of Nutritionen_US
dc.subjectEGCG-
dc.subjectFibrosis-
dc.subjectInflammation-
dc.subjectNAFLD-
dc.subjectOxidative stress-
dc.titleEpigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathwaysen_US
dc.typeArticleen_US
dc.identifier.emailXiao, J: jiaxiao@hku.hken_US
dc.identifier.emailHo, MCT: emike99@hku.hken_US
dc.identifier.emailLiong, EC: eclionga@hkucc.hku.hken_US
dc.identifier.emailLeung, TM: leungtm@hkucc.hku.hken_US
dc.identifier.emailFung, ML: fungml@hkucc.hku.hken_US
dc.identifier.emailTipoe, GL: tgeorge@hkucc.hku.hken_US
dc.identifier.authorityFung, ML=rp00433en_US
dc.identifier.authorityTipoe, GL=rp00371en_US
dc.identifier.doi10.1007/s00394-013-0516-8en_US
dc.identifier.pmid23515587-
dc.identifier.scopuseid_2-s2.0-84895076381-
dc.identifier.hkuros228197en_US
dc.identifier.volume53en_US
dc.identifier.issue1en_US
dc.identifier.spage187en_US
dc.identifier.epage199en_US
dc.identifier.isiWOS:000331079500017-
dc.publisher.placeGermany-
dc.identifier.issnl1436-6207-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats